Active, Not Recruiting
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
NCT06494150
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States